The term "discovery" in this context refers to the identification and development of these dihydropyrazino-benzimidazole derivatives as PAMs for mGluR2. This process typically involves extensive research, chemical synthesis, and testing to assess the compounds' efficacy, safety, and potential therapeutic applications.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.